Company · CIK 0001503802 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Karyopharm Therapeutics Inc. · KPTI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 2, 4:57 pm EDT | Kristin AbateChief Accounting Officer | 19 | $2.02 | $38 | 23,782 | −0.08% | |
| Jul 28, 2026 SForm 4 → | Jul 30, 4:42 pm EDT | Stuart PoultonEVP, Chief Development Officer | 189 | $7.10 | $1,342 | 94,632 | −0.20% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.